Dihexa is an experimental peptide compound derived from angiotensin IV, studied in laboratory and animal models for its effects on synaptogenesis — the formation of new connections between neurons. It is a research chemical, not an approved drug.

What does Dihexa research suggest?

Preclinical research suggests Dihexa may influence synapse formation, possibly through the HGF/c-Met signaling pathway, and animal studies have reported cognitive effects. These findings come from cell and rodent models; there is essentially no human evidence to confirm any benefit in people.

Is Dihexa approved or FDA-approved?

No. Dihexa is not an approved medicine in the US, EU, or elsewhere. It exists only as an experimental research chemical and has not been evaluated or authorized for human use by any regulatory agency.

There is no human safety data for Dihexa. Because it acts on a proliferative growth-factor pathway (HGF/c-Met), caution is warranted, and research-market material is not verified for purity or identity. Its safety profile in humans is unknown.

What are the side effects of Dihexa?

The side-effect profile of Dihexa in humans is unknown because no controlled human studies have characterized it. Any statements about tolerability are speculative given the absence of clinical data.

Dihexa is generally sold only as a research chemical and is not approved for human consumption. Its legal status varies by country and it is not marketed as a dietary supplement or medicine; this page does not provide sourcing or purchasing guidance.

How is Dihexa related to angiotensin IV?

Dihexa was engineered from angiotensin IV, a small fragment of the angiotensin peptide system that researchers noticed could improve memory in animals. The native fragment is broken down very quickly in the body, so chemists modified its structure to create a more stable, longer-lasting analog. In short, Dihexa is a lab-designed descendant of a naturally studied peptide, not a naturally occurring one itself. This is educational background only, not a recommendation to use it.

Why is Dihexa often described as extremely potent?

Early preclinical reports described synapse-forming activity at very low concentrations, which is where its reputation for 'potency' comes from. It is important to be evidence-honest here: potency in a cell dish or rodent model does not translate into proven, safe, or predictable effects in humans, and no human trials have established a meaningful dose or benefit. High potency in preclinical work can also raise, rather than lower, the need for caution.

What is the significance of the HGF/c-Met pathway mentioned with Dihexa?

Preclinical research proposed that Dihexa acts through hepatocyte growth factor (HGF) and its receptor c-Met, a signaling system involved in tissue growth and repair. That same pathway is also involved in cell proliferation, which is one reason researchers flag the importance of careful long-term safety evaluation for compounds that engage it. This is a mechanistic discussion point from the literature, not a health claim.

Where can I buy Dihexa and compare vendors?

Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Cognitive

Buy Dihexa – Vendors, Prices, Testing and Evidence

Buy Dihexa

Also known as: N-hexanoic-Tyr-Ile-(6) aminohexanoic amide

Evidence grade D — Anecdotal

Short answer

An experimental peptide discussed for potent effects on synaptic connections. Human data is essentially absent.

Where can you buy Dihexa?

No peptide-specific vendor offer is currently verified. The vendor catalogue link is provided for discovery only and does not assert availability.

What is known?

Dihexa is an angiotensin-IV-derived compound studied for synaptogenesis.

What is not established?

Essentially none.

Safety

No human safety data; proliferative pathway involvement warrants caution.

Regulatory status

Not an approved medicine. Research chemical status.

Not medical advice. This educational reference is not diagnosis, treatment, prescribing, dosing or emergency guidance. Consult a qualified professional before making health-related decisions.

Vendor comparison

Buy Dihexa: compare vendors

The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.

What is it?

Dihexa is an angiotensin-IV-derived compound studied for synaptogenesis.

Research and evidence

Dihexa (chemically N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is an experimental peptide compound derived from angiotensin IV and studied in the laboratory for its effects on synapse formation. It belongs to the cognitive research category and is discussed primarily for synaptogenesis — the process by which new connections form between neurons. On peptides.cx it carries a low evidence grade (D), reflecting how little validated data exists: Dihexa is not an approved medicine anywhere and circulates only as a research chemical.

The scientific interest in Dihexa stems from preclinical work suggesting it may act through the hepatocyte growth factor (HGF) and its receptor c-Met, a pathway implicated in neuronal connectivity. Animal studies have reported cognitive effects, which is why the compound is frequently discussed in nootropic and neuro-repair circles. However, it is important to be precise about the evidence picture: the encouraging findings come from cell-culture and rodent models, not from controlled human trials. Human evidence for Dihexa is essentially absent, so claims about memory enhancement or neurological benefit in people remain unproven and should be treated as hypotheses rather than established facts.

Safety is a genuine open question. There is no human safety data for Dihexa, and its involvement in a proliferative growth-factor pathway (HGF/c-Met) is a reason for caution, since pathways that drive cell growth can carry theoretical risks that have not been characterized in this compound. Material sold on the research market is not manufactured or verified to pharmaceutical standards, so purity and identity cannot be assumed. This page is an educational reference intended to summarize what the science does and does not show — it is not medical advice, does not endorse use, and does not provide dosing or sourcing guidance.

Evidence grade: D

Essentially none. Preclinical cognitive effects reported.

Human evidence

Essentially none.

Animal and preclinical evidence

Preclinical cognitive effects reported.

Proposed mechanisms

Discussed HGF/c-Met pathway effects on synapse formation

Safety concerns and known side effects

No human safety data; proliferative pathway involvement warrants caution.

Unknown profile

Regulatory status

Not an approved medicine. Research chemical status.

Dihexa research timeline

1990s
Researchers studying angiotensin IV note that this small peptide fragment can enhance memory and learning in animal models, opening a line of work into angiotensin-IV-derived compounds for cognition.
Late 2000s
An academic laboratory (associated with Washington State University) works to convert the memory-active but metabolically fragile angiotensin IV fragment into a more stable, orally deliverable small molecule.
Early 2010s
Dihexa is first described in the peer-reviewed literature as a metabolically stabilized angiotensin-IV analog reported to promote synapse formation (synaptogenesis) at very low concentrations in preclinical models.
Early-to-mid 2010s
Follow-up preclinical papers propose that its synaptogenic activity works through the hepatocyte growth factor (HGF)/c-Met signaling pathway, and report cognitive benefits in rodent models of impairment.
Mid-2010s onward
Dihexa gains attention in nootropic and biohacking communities and is sold as a research chemical, despite the absence of published human clinical trials.
Early 2020s
Dihexa remains an experimental, unapproved compound: no completed human safety or efficacy trials have been published, and it has received no regulatory approval in any jurisdiction.

Frequently asked questions about Dihexa

What is Dihexa?: Dihexa is an experimental peptide compound derived from angiotensin IV, studied in laboratory and animal models for its effects on synaptogenesis — the formation of new connections between neurons. It is a research chemical, not an approved drug.
What does Dihexa research suggest?: Preclinical research suggests Dihexa may influence synapse formation, possibly through the HGF/c-Met signaling pathway, and animal studies have reported cognitive effects. These findings come from cell and rodent models; there is essentially no human evidence to confirm any benefit in people.
Is Dihexa approved or FDA-approved?: No. Dihexa is not an approved medicine in the US, EU, or elsewhere. It exists only as an experimental research chemical and has not been evaluated or authorized for human use by any regulatory agency.
Is Dihexa safe?: There is no human safety data for Dihexa. Because it acts on a proliferative growth-factor pathway (HGF/c-Met), caution is warranted, and research-market material is not verified for purity or identity. Its safety profile in humans is unknown.
What are the side effects of Dihexa?: The side-effect profile of Dihexa in humans is unknown because no controlled human studies have characterized it. Any statements about tolerability are speculative given the absence of clinical data.
Is Dihexa legal?: Dihexa is generally sold only as a research chemical and is not approved for human consumption. Its legal status varies by country and it is not marketed as a dietary supplement or medicine; this page does not provide sourcing or purchasing guidance.
How is Dihexa related to angiotensin IV?: Dihexa was engineered from angiotensin IV, a small fragment of the angiotensin peptide system that researchers noticed could improve memory in animals. The native fragment is broken down very quickly in the body, so chemists modified its structure to create a more stable, longer-lasting analog. In short, Dihexa is a lab-designed descendant of a naturally studied peptide, not a naturally occurring one itself. This is educational background only, not a recommendation to use it.
Why is Dihexa often described as extremely potent?: Early preclinical reports described synapse-forming activity at very low concentrations, which is where its reputation for 'potency' comes from. It is important to be evidence-honest here: potency in a cell dish or rodent model does not translate into proven, safe, or predictable effects in humans, and no human trials have established a meaningful dose or benefit. High potency in preclinical work can also raise, rather than lower, the need for caution.
What is the significance of the HGF/c-Met pathway mentioned with Dihexa?: Preclinical research proposed that Dihexa acts through hepatocyte growth factor (HGF) and its receptor c-Met, a signaling system involved in tissue growth and repair. That same pathway is also involved in cell proliferation, which is one reason researchers flag the importance of careful long-term safety evaluation for compounds that engage it. This is a mechanistic discussion point from the literature, not a health claim.
Where can I buy Dihexa and compare vendors?: Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Common discussion areas

CognitionSynaptogenesis

Sources

Editorial review and transparency

Written by: peptides.cx Editorial Team
Scientific reviewer: No named medical reviewer is currently assigned
Last editorial review: June 1, 2026
Last vendor check: July 18, 2026
Review method: Source review, claim verification, vendor-data separation and regulatory-context review.
Commercial disclosure and conflicts: Vendor relationships do not determine evidence or safety ratings. No named reviewer conflict is recorded because no named reviewer is assigned.

Editorial policy →Evidence grade →Vendor methodology →

Related on peptides.cx

Library →Vendor quality checklist →Safety →Affiliate code: PEPTIDES10